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ABSTRACT 
Although alcohol is known to be a carcinogen for humans, ethanol-genotoxicity studies 
are incomplete. Ethanol seems not to be a bacterial mutagen, but the results are 
conflicting in rodent assays. We investigate the genotoxicity in the bone marrow 
micronucleus (MN) test and in the dominant lethal mutation (DLM) assay using two 
long-term ethanol exposure protocols. In the MN test, mice consumed three doses (5, 
10 and 15% v/v) for 32 weeks. MN induction was compared to two control groups of 
5- and 38-week-old mice (the ages of the treated mice when the treatment was 
initiated and when they were killed, respectively). For the three groups treated with 
ethanol there was no significant increase in MN induction as compared to the first 
control group, but observed MN frequencies were significantly lower than in the 38-
week-old control group. This suggests a protective effect against genotoxic damage 
caused by aging, probably due to ethanol action as a hydroxyl radical scavenger. 
In the DLM assay, male mice drank ethanol at 15% or 30% (v/v) for 20 weeks. In both 
groups the number of dead implants was similar to the control, but there was a 
significant reduction in total implants, indicating a pre-implantation loss. 
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 INTRODUCTION 
Chronic alcoholism is a mayor public health issue around the world. Consumption of 
alcohol has been related to cardiovascular diseases (Friedman, 1998), hepatic effects 
(Lieber, 1985), brain toxicity (Harper, 1998), and increased incidence of esophagus, 
larynx and oral cavity cancers. The International Agency for Research on Cancer 
(IARC, 1998) has found that there is sufficient evidence for the carcinogenicity of 
alcoholic beverages in humans, and has classified alcoholic beverages as Group I 
carcinogens, although the mechanism of ethanol carcinogenicity is still not known 
(Kayani and Parry, 2010). 
There are many studies about the genotoxic potential of ethanol, some of which have 
shown chromosomal effects in lymphocytes of alcoholics, like sister chromatid 
exchanges (reviewed in Obe and Anderson, 1987), induction of chromosomal 
aberrations (López et al., 2001) and increased incidence of aneuploidy (Kucheira et al., 
1986), suggesting that alcoholism may cause chromosome damage in humans. 
The genotoxicity testing of ethanol was first reviewed by an expert group of the 
International Commission for the Protection against Environmental Mutagens and 
Carcinogenesis (ICPEMC) (Obe and Anderson, 1987). No conclusion was reached about 
the effects of ethanol in relation to genetic damage. In 1995, the UK Department of 
Health's Committee on Mutagenesis of Chemicals in Food, Consumer Products and the 
Environment reviewed the evidence for the mutagenecity of ethanol, acetaldehyde and 
alcoholic beverages. The Committee agreed that the consumption of alcoholic 
beverages does not present any significant concern with respect to their mutagenic 
potential. 
In 2001, Phillips and Jenkinson (Phillips and Jenkinson, 2001) made a review of the 
available information on the genotoxicity of ethanol, concluding that the data derived 
from studies using standard genotoxicity methods are incomplete. They reported that 
there is clear evidence that ethanol is not a bacterial or mammalian mutagen, but the 
results of some in vivo rodent assays are conflicting. The reported tests for 
chromosome aberrations in vivo are all negative, a minority of micronucleus tests have 
given positive results, dominant lethal assays are divided between positive and 
negative, and there is some limited evidence that high doses of ethanol can induce 
sister chromatid exchanges (SCE) and aneunogenic effects. 
More recently, in vitro micronucleous (MN) tests with human TK6 cells showed non-MN 
induction with ethanol exposure up to 1.6% (v/v) (Bryce et al., 2007), while the 
cytokinesis blocked micronucleous assay (CBMN) revealed a dose dependent increase 
in the mean frequency of binucleated cells with MN with 0.8, 1.0 and 2.0% (v/v) of 
ethanol (Kayani and Parry, 2010) 
The present study investigated the genotoxic potential of ethanol by using long-term 
exposure protocols to simulate chronic alcoholism in a mouse micronucleus bone 
marrow test and a mouse dominant lethal mutation assay. 
MATHERIAL AND METHODS 
Chemical Reagents 
Ethanol (CAS N° 6417-5) was obtained from Merck Chemical Co. (Germany). 
Animals and treatments 
CF1 mice were obtained from the National Health Institute of Chile. They were kept 
with water and pellets (mouse chow Kimber, Chile) ad libitum, with a controlled 
temperature (24°C) and humidity (40 - 50%) and a 12-hour light-dark cycle. During 
the study animals were kept under the same environmental conditions, except that 
ethanol treated groups received ad libitum an aqueous ethanol solution instead of 
water. Since mice do not like the taste of ethanol, we first began the ethanol treatment 
with a very low dose, which was daily increased to 5, 10, 15 or 30% (v/v) 
Micronucleus Assay 
For chronic ethanol treatment, three groups of male mice (n=6) drank an aqueous 
solution of ethanol with concentrations of 5, 10 or 15% (v/v) from 5 to 38 weeks of 
age. Control animals (n=6) received only water for the same period of time. The 
mouse bone marrow micronucleus assay was performed as previously reported 
(Ellahueñe et al., 1994). For each animal, 2000 polychromatic erythrocytes (PCE) were 
scored, and cytotoxicity was measured as the ratio of PCE/NCE 
(normochromatic erythrocytes) in 200 total erythrocytes. The results were analyzed 
statistically by the Mann-Whitney U test, with the level of significance set at a = 0.05. 
Dominant Lethal Mutation Assay 
Two groups of male mice (n=10) were exposed to 15% or 30% (v/v) of ethanol in the 
drinking water, as the only choice of liquid, from 10 to 30 weeks old. The control group 
(n=10) received only water for the same period of time. After the exposure interval, 
the ethanol solution was replaced by water in order to have minimal effects on mating 
performance. Each male was separately caged with two virgin females; each morning 
the females were examined for the presence of the vaginal plug, mated females were 
replaced and non-mated females were kept in cages. This mating procedure was 
performed for three consecutive days. The mated females were killed by cervical 
dislocation 12 days after the vaginal plug was observed and each uterus was removed 
and examined for the number and status of all implantation sites. The numbers of total 
live and dead implants were scored. The percentage of induced dominant lethal 
mutations (DLM) was calculated as: 
 
The results were analyzed statistically by the student's t test, with the level of 
significance set at a = 0.05. 
RESULTS 
Table I shows the micronucleus bone marrow test results. There were no significant 
increases in induced MNPCEs at any of the ethanol doses (5, 10, or 15% v/v) as 
compared to the 5-week-old control group. In addition, no differences were observed 
among the three doses. However, there were significant differences in induced MN 
between the two control groups, 2.7 ± 1.2 in 5-week-old mice and 6.5 ± 3.0 in 38-
week-old mice. As well, the MN frequencies observed in the three ethanol treated 
groups were all significantly lower than the values observed in the 38-week-old control 
group. 
 
 
The PCE/NCE ratio was within the normal range (>0.1) for both the treatment and 
control groups, showing no cytotoxic effect of ethanol ingestion on the cell population. 
Dominant lethal mutation results are summarized in Table II. The number of total 
implants per pregnant female is similar for both ethanol doses, and significantly lower 
than the number observed in the control group. The mean numbers of living embryos 
per pregnant female also decreased in both ethanol treated groups, but not to 
statistically significant levels. No differences were observed for the mean number of 
dead implants, and the percentage of DLM was low and similar for both ethanol doses. 
DISCUSSION 
Alcohol abuse greatly increases the risk of different malignancies, including cancer, but 
the mechanisms by which ethanol could be a carcinogenic or co-carcinogenic agent 
remain unknown. The available data from studies on ethanol using standard 
genotoxicity methods are incomplete and inconclusive (Phillips and Jenkinson, 2001). 
Nevertheless, some studies have shown that chronic alcoholism may cause 
chromosome damage in humans, such as chromosome aberrations in peripheral blood 
lymphocytes (Burim et al., 2004), centromere positive MN in lymphocytes (Maffei et 
al., 2000), or micronuclei in tongue cells (de Almeida et al., 2002), suggesting a 
relationship between excessive consumption of ethanol-containing beverages and 
some degree of genotoxicity. On the other hand, the reports for chromosomal 
aberrations in vivo, designed to model the effects of alcoholism in animals, were all 
negative. Ethanol showed no effect on micronucleous incidence in rat bone marrow, 
when ethanol was administered in drinking water at 5% for 10-30 days (Balansky et 
al., 1993) or at 10% and 20% for 3 to 7 weeks (Tates et al., 1980). As well, a non-
significant increase in chromosomal aberration frequency was observed at 20% of 
ethanol administered for 30 days (Tavares et al., 2001). These negative results could 
be the consequence of the short exposure time period (30 days), or the small number 
of animals (Tates et al., 1980). However, if ethanol per se is neither carcinogenic nor 
mutagenic, it could act as an enhancer for carcinogenicity. In this way it has been 
suggested that the ability of ethanol to induce CYP2E1 (Guegerich et al., 1994) could 
be the mechanistic basis of ethanol for enhancement of genotoxicity and 
carcinogenicity in mixtures containing carcinogens, such as alcoholic beverages (which 
contain urethane, and probably other known carcinogens). In support of this 
suggestion, alcoholic beverages, such as tequila and brandy, were demonstrated to be 
more genotoxic with the sister chromatid exchange test in mouse bone marrow cells 
than was ethanol itself (Pina Calva and Madrigal-Bujaidar, 1993). 
In this work, we investigated the possible genotoxic effects of chronic ethanol 
exposure, so mice were drinking ethanol for a longer period of time than that used in 
the other cited in vivo ethanol studies. In the mouse bone marrow micronucleus assay 
(Table I), we observed that all ethanol doses tested did not increase the MNEPC 
frequency as compared to that in control animals. Because it has been reported that 
the MNEPC frequency increases in mice with age (Sato, 1995, Dass et al., 1997), we 
used two control groups, one 5 weeks old, the age at which the treated mice began 
drinking ethanol, and the other 38 weeks old, the age at which the treated mice were 
killed after drinking ethanol. Surprisingly, we observed that the MNEPC frequency was 
significantly lower in the three ethanol-treated groups compared to the 38-week-old 
control group, suggesting an ethanol protective effect against genotoxic damage 
caused by aging. This low MN frequency observed in our experiment could not be 
ascribed to an ethanol cytotoxicity effect, because the EPC/ENC ratio is within the 
normal range (> 0.1) in all of the treated and control animals (Table I). 
Ethanol has previously been reported as a genotoxic protective agent. Different 
injected ethanol doses have been shown to reduce the induction of mouse MNEPC by 
urethane (Choy et al., 1995). The same authors also demonstrated that ethanol delays 
urethane genotoxicity for 12 hours (Choy et al., 1996). 
Other authors have reported a radioprotective effect of ethanol. The addition of 10 mM 
ethanol reduced X-ray-induced chromosome aberrations in human lymphocytes in 
vitro, while ethanol was less effective in protection from carbon-induced chromosome 
aberrations. Since densely ionizing radiation produces lesions through direct action, 
while other ionizing radiation, like X-rays or g-rays, induces DNA lesions mostly by 
indirect action where free radicals play an important role, the authors concluded that 
ethanol protects DNA from X rays by scavenging hydroxyl (OH) radicals (Monobe and 
Ando, 2002). The same authors found that in mice that are given 1 ml of 5.5% ethanol 
orally 30 min before whole body irradiation, chromosome aberrations in spleen cells 
were significantly reduced by ethanol for g-ray irradiation, but not for carbon-ion 
irradiation (Monobe et al., 2003). These results may confirm the hypothesis that 
ethanol acts as a free radical scavenger. In human lymphocytes, ethanol showed a 
protective effect for hydrogen peroxide-induced DNA damage in vitro (Greenrod and 
Fenech, 2003), also apparently by acting as a free radical scavenger. 
Paradoxically, oxidative metabolism of ethanol has been described as the mechanism 
by which ethanol can induce genotoxicity damage and some authors have 
demonstrated that antioxidants could markedly decrease the levels of ethanol induced 
DNA single-strand breaks in mouse brain cells (Guo et al., 2007) 
The primary site of ethanol absorption is the gastrointestinal tract. Only 2% - 10% of 
the total ethanol ingested is eliminated by the kidney, and the rest is mainly oxidized 
in the liver (Lieber, 1997). Ethanol oxidation occurs in three places in hepatocytes, by 
different pathways: (a) in the cell cytoplasm by alcohol dehydrogenase; (b) in the 
endoplasmic reticulum by the microsomal ethanol oxidation system (MEOS); and (c) in 
the peroxisomes by catalase (Burim et al., 2004). Each of these three oxidation 
processes produces specific metabolites. 
The first phase of ethanol biotransformation involves its oxidation to acetaldehyde, the 
main and primary metabolite of ethanol. Acetaldehyde is a highly reactive compound 
that can interact with DNA, forming DNA adducts of acetaldehyde like those observed 
in peripheral white blood cells of alcohol abusers (Fang and Vaca, 1995), or DNA 
strand breaks (Singh and Khan, 1995) and DNA cross-links in cultured human 
lymphocytes (Blasiak et al., 2000). Thus, the high levels of acetaldehyde accumulated 
during ethanol metabolism could be responsible for the positive genotoxic effects of 
ethanol reported in some papers. According to many authors, ethanol does not possess 
genotoxic potential and the observed ethanol genotoxicity is only due to acetaldehyde. 
Nevertheless, Kayani and Parry (2010) have shown that both ethanol and 
acetaldehyde can produce significant increases in MN induction, establishing that 
ethanol-MN induction is mainly through an aneugenic mechanism, while acetaldehyde 
does the same through a clastogenic effect. Different factors could regulate the rates 
of alcohol and acetaldehyde metabolism. One of these factors is alcohol 
deshydrogenase (ADH) and acetaldehyde deshydrogenase (ALDH) polymorphisms, 
both enzymes being primarily responsible for the amount of acetaldehyde generated. 
There could be a relationship between polymorphisms of ethanol-induced metabolism 
genes and alcoholism (Chen et al., 2009), and an effect has been observed of drinking 
alcohol and ADH/ALDH polymorphism on DNA damage, as measured by the alkaline 
comet assay (Weng et al., 2010). Thus, human polymorphisms of these enzymes could 
explain the different effects of the ethanol consumed by alcoholics. 
Chronic ethanol consumption leads to its oxidation by MEOS, where P4502E1 is the 
main component of this system, generating an adaptive increase of ethanol 
metabolism (Lieber, 1997). This adaptation and/or tolerance to high concentrations of 
ethanol has been suggested to prevent ethanol that has entered the circulation from 
reaching excessive levels, so this progressively increasing rate of ethanol clearance 
from blood could explain the lack of genotoxic effect of chronic ethanol administration 
in rats (Tavares et al., 2001), as well as our negative results in mice. Furthermore, 
together with a lack of genotoxic effect, we also observed less genotoxic effects in 
older mice chronically exposed to ethanol. We suggest this could also be explained by 
ethanol metabolic pathways. Since oxidative damage of macromolecules plays a 
significant role in the aging of rodents (Martin et al., 1996) and enzymes involved in 
free radical detoxification, such as superoxide dismutase and catalase, are known to 
decrease in the liver and brain of mice with age (Dass et al., 1997), the genotoxic 
protection effect of ethanol could be due to ethanol acting as a hydroxyl radical 
scavenger by reducing free radical production. Chronic alcohol consumption could 
stimulate catalase activity, which is involved in ethanol oxidation, producing an 
adaptive increase similar to that observed for CYP2E1 activity. This hypothesis could 
also explain the absence of a synergistic or additive genotoxic effect of ethanol 
combined with cigarette smoke observed in alcoholic smokers (Burim et al., 2004), 
and the increase of cells with chromosomal aberrations in chronic alcoholics after 12 
months of abstinence in comparison to the frequency at the beginning of an intensive 
treatment program (Huttner et al., 1999). 
In germ cells, the dominant lethal mutation assay (Table II) gave no evidence of a 
significant increase in post-implantation lethality, while a moderate but significant 
reduction in mean total implants was observed, indicating pre-implantation loss. These 
results are similar to those reported by Rao et al, who found a significant reduction in 
mean total implants in a Swiss strain, but not in CBA mice after acute ethanol 
treatment (Rao et al., 1994). Thus, our results exclude the possibility that chronic 
ethanol exposure could induce germinal chromosome mutations in mice. 
Finally, our results show that chronic treatment with ethanol does not induce genotoxic 
damage in somatic or germinal mouse cells evaluated by the micronucleus or the 
dominant lethal mutation assays. This suggests that ethanol could have a protective 
effect on age-related genotoxic damage, presumably due to free radical scavenging by 
ethanol, although further studies are required to confirm this effect and to elucidate 
the underlying mechanism. 
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